Pfizer is poised to start selling Inflectra, its version of the blockbuster rheumatoid arthritis drug Remicade. But the price of Inflectra is only 15 percent less.
The unemployment rate for transgender people is double that of the general population. A new program aims to change that. It's all because of a trans woman who's employed trans people for years.
In two decades, Subaru has gone from struggling carmaker to steady success. What changed the company's fate? An ad campaign aimed at a group of consumers other automakers were ignoring.
Five of the largest agrochemical chemical companies are currently involved in mergers that may lead to four companies controlling many of the basics that big grain farmers use to grow food globally.
A report from a brand-consulting firm suggests that if the presidential candidates were cereal brands they probably wouldn't be on your breakfast table.
It's a toss-up between lack of disclosure, if the problem is known, and lack of accountability, if the causes of early fire reports were unknown or misdiagnosed but blamed on the battery nonetheless.